Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorCasabona, Jordi
dc.contributor.authorBrugal, Teresa
dc.contributor.authorMajor Roca, Xavier
dc.contributor.authorMeroño, Mercè
dc.contributor.authorEspelt, Albert
dc.contributor.authorGonzález, Victoria
dc.contributor.authorGrupo Redan
dc.contributor.authorFolch, Cinta
dc.date.accessioned2022-03-15T11:10:27Z
dc.date.available2022-03-15T11:10:27Z
dc.date.issued2012-01
dc.identifier.citationFolch C, Casabona J, Brugal MT, Majó X, Meroño M, Espelt A, et al. Perfil de los usuarios de drogas por vía parenteral que mantienen conductas de riesgo relacionadas con la inyección en Cataluña. Gac Sanit. Jan-Feb 2012;26(1):37-44.
dc.identifier.issn1578-1283
dc.identifier.urihttps://hdl.handle.net/11351/7183
dc.descriptionDrug injection; VIH; Harm reduction centers
dc.description.abstractObjectives: To estimate the prevalence of direct and indirect syringe sharing among intravenous drug users (IDUs) attending a harm reduction center in Catalonia (Spain) and to identify factors associated with risk behaviors. Methods: A cross-sectional study was conducted between 2008 and 2009 in harm reduction centers. Behavioral data were collected using anonymous questionnaires administered by trained interviewers. Results: Of the 748 respondents, 31.5% had shared syringes at least once in the previous 6 months and 55.2% reported sharing injection paraphernalia (spoons, water, filters). A higher risk of syringe sharing was found among IDUs who injected daily (OR = 1.5), injected cocaine (OR = 1.6), had less than half their supply of syringes from a free source (OR = 2.5), had an IDU sexual partner (OR = 1.8) or who reported indirect sharing (OR = 4.1). A higher risk of indirect sharing was found in respondents who had an illegal source of income (OR = 1.5), injected daily (OR = 1, 5), injected cocaine (OR = 1.4), reported sharing syringes (OR = 3.9), or who reported a previous overdose (OR = 1.5). Conclusions: Despite the widespread use of harm reduction programs in Catalonia, a significant proportion of IDUs continue to practise injection-related risk behaviors. Further reductions in risk behaviors could be achieved by improving access to all sterile injecting equipment, especially among cocaine injectors and IDUs who inject frequently, and by including IDU sexual partners within the current network of harm reduction centers.
dc.language.isospa
dc.publisherElsevier España
dc.relation.ispartofseriesGaceta Sanitaria;26(1)
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.sourceScientia
dc.subjectDrogoaddicció - Estudi de casos
dc.subjectCentres per a drogoaddictes - Catalunya
dc.subject.meshHarm Reduction
dc.subject.meshDrug Users
dc.subject.meshCatalonia
dc.titlePerfil de los usuarios de drogas por vía parenteral que mantienen conductas de riesgo relacionadas con la inyección en Cataluña
dc.title.alternativeCharacteristics of intravenous drug users who share injection equipment in Catalonia (Spain)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.gaceta.2011.07.022
dc.subject.decsreducción de daños
dc.subject.decsconsumidores de drogas
dc.subject.decsCataluña
dc.relation.publishversionhttps://doi.org/10.1016/j.gaceta.2011.07.022
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Folch C] Centre d’Estudis Epidemiològics sobre les ITS i Sida a Catalunya (CEEISCAT), Institut Català d'Oncologia (ICO), Badalona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Programa de Doctorat en Salut Pública i Metodologia de la Recerca Biomèdica, Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Barcelona, Spain. [Casabona J] Centre d’Estudis Epidemiològics sobre les ITS i Sida a Catalunya (CEEISCAT), Institut Català d'Oncologia (ICO), Badalona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Programa de Doctorat en Salut Pública i Metodologia de la Recerca Biomèdica, Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Barcelona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. [Brugal MA] . Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Agència de Salut Pública de Barcelona, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Majó X] Subdirecció General de Drogodependències, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Meroño M] Fundació Àmbit Prevenció, Barcelona, Spain. [Espelt A] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Agència de Salut Pública de Barcelona, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Departament de Psicobiologia i Metodología de les Ciències de la Salut, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. [González V] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Servicio de Microbiología, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
dc.identifier.pmid22088906
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record